| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G/A | 2024-02-12 | BlackRock Inc. | SMITH & NEPHEW PLC | - | - | EDGAR |
| SC 13G/A | 2024-02-12 | BlackRock Inc. | SMITH & NEPHEW PLC | 80,702,924 | 9.2% | EDGAR |
| SC 13G/A | 2023-05-05 | BlackRock Inc. | SMITH & NEPHEW PLC | 88,856,509 | 10.2% | EDGAR |
| SC 13G/A | 2023-01-24 | BlackRock Inc. | SMITH & NEPHEW PLC | 81,077,849 | 9.3% | EDGAR |
| SC 13G/A | 2022-02-07 | BlackRock Inc. | SMITH & NEPHEW PLC | 75,116,146 | 8.5% | EDGAR |
| SC 13G | 2022-02-07 | SMITH & NEPHEW PLC | Bioventus Inc. | 22,016,728 | 29.3% | EDGAR |
| SC 13G/A | 2021-02-03 | WELLINGTON MANAGEMENT GROUP LLP | SMITH & NEPHEW PLC | 42,665,590 | 4.9% | EDGAR |
| SC 13G/A | 2021-02-01 | BlackRock Inc. | SMITH & NEPHEW PLC | 78,408,020 | 8.9% | EDGAR |
| SC 13G/A | 2020-02-06 | BlackRock Inc. | SMITH & NEPHEW PLC | 74,541,363 | 8.5% | EDGAR |
| SC 13G/A | 2020-01-28 | WELLINGTON MANAGEMENT GROUP LLP | SMITH & NEPHEW PLC | 49,610,408 | 5.7% | EDGAR |
| SC 13G | 2019-02-12 | WELLINGTON MANAGEMENT GROUP LLP | SMITH & NEPHEW PLC | 54,963,086 | 6.3% | EDGAR |
| SC 13G/A | 2019-02-06 | BlackRock Inc. | SMITH & NEPHEW PLC | 59,553,786 | 6.8% | EDGAR |
| SC 13G/A | 2018-01-30 | BlackRock Inc. | SMITH & NEPHEW PLC | 64,095,526 | 7.3% | EDGAR |
| SC 13G/A | 2017-01-27 | BlackRock Inc. | SMITH & NEPHEW PLC | 54,920,533 | 6.3% | EDGAR |
| SC 13G/A | 2016-01-27 | BlackRock Inc. | SMITH & NEPHEW PLC | 51,863,814 | 5.8% | EDGAR |
| SC 13D | 2014-02-12 | SMITH & NEPHEW PLC | ARTHROCARE CORP | 6,614,746 | 19.0% | EDGAR |
| SC 13D/A | 2002-10-15 | SMITH & NEPHEW PLC | ADVANCED TISSUE SCIENCES INC | 5,104,163 | 7.0% | EDGAR |
| SC 13D | 2002-02-22 | SMITH & NEPHEW PLC | ORATEC INTERVENTIONS INC | 3,248,426 | 14.0% | EDGAR |